RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 11.448
NA - Nord America 4.014
EU - Europa 2.155
SA - Sud America 559
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 85
OC - Oceania 16
Totale 18.402
Nazione #
SG - Singapore 8.990
US - Stati Uniti d'America 3.830
IT - Italia 1.140
CN - Cina 1.127
HK - Hong Kong 595
BR - Brasile 395
VN - Vietnam 261
GB - Regno Unito 224
FR - Francia 219
DE - Germania 181
BD - Bangladesh 140
IN - India 96
NL - Olanda 96
CA - Canada 85
AR - Argentina 59
EE - Estonia 57
FI - Finlandia 49
ID - Indonesia 46
MX - Messico 43
ZA - Sudafrica 31
EC - Ecuador 30
TR - Turchia 28
IQ - Iraq 25
CO - Colombia 21
UA - Ucraina 21
SE - Svezia 20
ES - Italia 18
JP - Giappone 18
AT - Austria 17
CL - Cile 16
CZ - Repubblica Ceca 16
RU - Federazione Russa 15
SA - Arabia Saudita 15
PH - Filippine 14
PL - Polonia 14
AU - Australia 13
PE - Perù 12
PK - Pakistan 12
MD - Moldavia 11
JM - Giamaica 10
TN - Tunisia 10
VE - Venezuela 10
MA - Marocco 9
RO - Romania 9
CR - Costa Rica 8
KZ - Kazakistan 8
UZ - Uzbekistan 8
EG - Egitto 7
GT - Guatemala 7
NI - Nicaragua 7
DO - Repubblica Dominicana 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
UY - Uruguay 6
BO - Bolivia 5
CH - Svizzera 5
HU - Ungheria 5
MY - Malesia 5
TH - Thailandia 5
TW - Taiwan 5
AZ - Azerbaigian 4
DZ - Algeria 4
IE - Irlanda 4
IL - Israele 4
JO - Giordania 4
OM - Oman 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
GE - Georgia 3
PA - Panama 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CI - Costa d'Avorio 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HT - Haiti 2
IR - Iran 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BJ - Benin 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
Totale 18.247
Città #
San Jose 1.242
Singapore 775
Rome 675
Ashburn 626
Hong Kong 526
Hefei 394
Council Bluffs 296
Beijing 271
Dallas 226
Columbus 216
Boardman 197
Lauterbourg 191
London 174
Shanghai 138
Munich 104
Ho Chi Minh City 98
New York 98
Los Angeles 74
Santa Clara 72
Hanoi 58
Amsterdam 43
San Francisco 38
Naples 34
São Paulo 30
Milan 28
Turku 28
Pune 27
Washington 27
Chicago 26
Seattle 26
Toronto 24
Helsinki 21
Mexico City 19
Brooklyn 18
Atlanta 15
Montreal 15
Chennai 14
Las Vegas 14
Orem 13
Quito 13
Boston 12
Brno 12
Buffalo 12
Charlotte 12
Haiphong 12
Johannesburg 12
Palermo 12
Rio de Janeiro 12
Florence 11
Phoenix 11
Sona 11
Tokyo 11
Frankfurt am Main 10
Lima 10
Nuremberg 10
St Louis 10
Stockholm 10
Warsaw 10
West Jordan 10
Bogotá 9
Guayaquil 9
Jakarta 9
Manchester 9
Biên Hòa 8
Bologna 8
Curitiba 8
Da Nang 8
Guangzhou 8
Hải Dương 8
Manaus 8
San José 8
Tashkent 8
Baghdad 7
Bari 7
Brasília 7
Buenos Aires 7
Dhaka 7
Managua 7
Santiago 7
Ankara 6
Belo Horizonte 6
Denver 6
Guarulhos 6
Guatemala City 6
Hangzhou 6
Hanover 6
Miami 6
Nairobi 6
New Delhi 6
Redmond 6
Dammam 5
Jinan 5
Marseille 5
Melbourne 5
Montevideo 5
Pasadena 5
Providence 5
Rocca di Papa 5
Salvador 5
Santo André 5
Totale 7.407
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 344
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 331
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 279
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 256
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 256
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 246
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 240
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 233
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 231
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 231
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 229
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 227
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 224
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 223
Exploring Deep Pathomics in Lung Cancer 222
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 221
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 220
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 219
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 219
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 219
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 217
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 216
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 215
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 214
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 211
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 211
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 208
Preventing Cardiotoxicity in Personalized Breast Irradiation 203
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 202
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 200
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 193
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 189
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 168
A deep learning approach for overall survival prediction in lung cancer with missing values 166
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 159
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 158
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 142
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 141
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 140
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 135
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 135
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 133
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 133
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 133
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 132
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 129
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 129
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 128
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 128
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 127
Evaluating GANs in Medical Imaging 127
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 125
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 125
MR imaging of rectal cancer before and after chemoradiation therapy 123
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 121
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 120
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 119
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 116
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 115
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 114
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 113
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 112
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 112
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 110
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 108
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 108
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 107
Chemoradiation for stage III non-small cell lung cancer 105
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 103
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 96
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 95
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 88
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 85
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 84
Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis 75
Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort 70
Precision radiotherapy by SPECT lung functional imaging in NSCLC 69
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 67
Role of PSA levels and pathological stadiation before radiation therapy in predicting mp-MRI results in patients with prostate cancer recurrence after radical prostatectomy 66
Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study 64
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 63
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes 63
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis 63
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 60
Protective Role of Natural Compounds under Radiation-Induced Injury 60
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 59
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 58
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 58
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 58
Radiation therapy of breast cancer. Reasoned approach to a clinical case 57
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 55
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 55
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 54
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 54
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. 53
Protective Effects of Grape Seed Extract on Lipopolysaccharide Exposure and Radiation-Induced Intestinal Mucosal Damage: Insights from an In Vitro Study 52
V5 and High Sensitivity Cardiac Troponin T for Early Detection of Cardiac Toxicity During Left Breast Cancer Irradiation 52
Locally advanced NSCLC: how to improve disease control? 52
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement 52
Stage III NSCLC treatment options: too many choices 51
Totale 14.036
Categoria #
all - tutte 96.344
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.344


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022220 0 6 6 5 1 3 6 6 13 7 0 167
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024590 21 62 36 35 60 250 14 35 4 22 11 40
2024/20259.985 95 48 220 64 111 218 153 34 520 723 3.590 4.209
2025/20266.820 612 324 483 740 294 400 1.803 474 560 586 290 254
2026/2027615 122 493 0 0 0 0 0 0 0 0 0 0
Totale 18.402